Journal of Interdisciplinary Histopathology



e-ISSN: 2146-8362



Journal Home | Instructions for Authors | Current Issue | Online First | Previous Issues

« Previous Article
Next Article »

Review Article Open Access


Renal Biopsy for Research: An Overview of Russian Experience

Sergei V. Jargin.

Cited by (4)

Abstract
Renal biopsy is a relatively safe procedure with a well-defined risk profile. A biopsy for research is one that is carried out without clinical indications purely for research purposes. Research biopsies often have a parallel clinical purpose, therefore requiring more tissue to be sampled. Research as a purpose of a renal biopsy presupposes informed consent. This review is discussing several publications from the past, but the problem is still with us: invasive procedures performed primarily for research sometimes of questionable reliability. In the author’s opinion, renal biopsy should always be performed according to clinical indications. If the patient gives consent to research on the renal tissue obtained for the diagnostic purposes, it can be done, provided that enough tissue remains for the diagnostics, and that Institutional Review Committee approves of the research project.

Key words: renal biopsy; glomerulonephritis; pyelonephritis; Alport syndrome; alcoholism


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Sergei V. Jargin
on Google
on Google Scholar
Article Statistics
 Viewed: 2399
Downloaded: 470
Cited: 4

REFERENCES
1. Dhaun N, Bellamy CO, Cattran DC, Kluth DC. Utility of renal biopsy in the clinical management of renal disease. Kidney Int 2014 [DOI via Crossref]    [DOI via Crossref]   
2. The Nuremberg Code. Washington, D.C.: U.S. Government Printing Office, 1949. Available via http://history.nih.gov/research/downloads/nuremberg.pdf (Accessed 11 March 2014)
3. Dzhanaliev BR, Varshavskii VA, Laurinavicius AA. Primary glomerulopathies: incidence, dynamics and clinical manifestations of morphological variants. Arkh Patol 2002; 64(2): 32-35.
4. Kirillov IuA. Morphogenesis of acute pyelonephritis (electron microscopic study). Arkh Patol 1979; 41(8): 29-36.
5. Kirillov IuA. Morphogenesis of chronic pyelonephritis (electron microscopic study). Arkh Patol 1980; 42(1): 38-45.
6. Tisher CC. Clinical indications for kidney biopsy. In: Tisher CC, Brenner BM (eds) Renal pathology, Lippincott, Philadelphia, USA, pp 2-10, 1989.
7. Kasiske BL, Keane WF. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy. In: Brenner BM (ed) Brenner & Rector's The Kidney, 6th edition, Saunders Co., Philadelphia, USA, pp 1129-1170, 2000.
8. Tomson CR. Indications for renal biopsy in chronic kidney disease. Clin Med 2003; 3(6): 513-517. [DOI via Crossref]    [Pubmed]   
9. Pal'tsev MA. Juxtaglomerular apparatus and interstitial cells of kidney medulla in hydronephrosis and chronic pyelonephritis. Arkh Patol 1982; 44(5): 12-19.
10. Lentner C. Wissenschaftliche Tabellen Geigi, CIBA-GEIGI, Basel, Switzerland, 1980.
11. Serov VV, Pal'tsev MA. Endocrine system of the kidneys in nephrogenic arterial hypertension: functional and morphological analysis. Arkh Patol 1984; 46(11): 5-16.
12. Pal'tsev MA, Bespalov DA, Shliapnikov VV, Kutyrina IM, Nikishova TA. Juxtaglomerular apparatus and interstitial cells of the kidney medulla in glomerulonephritis. Arkh Patol 1984; 46(2): 64-70.
13. Mukhin NA, Popova EN, Fomin VV, Popova IA, Kuznetsova AV, Ponomarev AB, Pal'tseva EM, Churganova LIu, Osipenko VI. Clinical significance of markers of endothelial dysfunction and angiogenesis in progressing of the lung interstitial diseases. Ross Fiziol Zh Im I M Sechenova 2009; 95(10): 1139-50.
14. Kazeko NI, Zhmurov VA, Borovskii AA, Veshkurtsev VV, Khvan OV. Lipids content in renal tissue membranes in patients with urolithiasis and secondary pyelonephritis. Urologiia 2005; (5): 56-58.
15. Jargin SV. Renal biopsy research in the former Soviet Union: prevention of a negligent custom. ISRN Nephrology 2013; 2013: 980859. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
16. Diusiubaev AA, Shalashov VA. Thin needle aspiration biopsy of the kidneys in diagnosis of acute pyelonephritis. Urologiia 2007; (6): 29-31.
17. Shulutko BI, Tsykin DB, Zus' BA. Clinico-morphological comparisons in secondary renal amyloidosis. Urol Nefrol (Mosk) 1986; (1): 31-35.
18. Sarkisova IA, Rameev VV, Varshavskii VA, Golitsyna EP, Kozlovskaia LV. An AA-amyloidosis course in patients with rheumatoid arthritis. Ter Arkh 2006; 78(5): 31-36.
19. Pal'tsev MA, Iargin SV, Krotovskii GS, Turpitko SA, Mamedov DM. Importance of morphologic examination of the kidneys of patients with vasorenal hypertension for predicting the results of surgical treatment. Arkh Patol 1986; 48(6): 34-40.
20. Romanenko AM, Nosov AT, Pereverzev AS, Zubko VI. Morphologic changes of the kidneys in patients with vasorenal hypertension. Vrach Delo 1989; (6): 35-38.
21. Arabidze GG, Pogrebnaia GN, Todua FI, Sokolova RI, Kozdoba OA. Hypertensive disease and renal hypertension (structural and functional studies of the kidneys using dynamic computerized tomography). Kardiologiia 1989; 29(11): 53-56.
22. Shkhvatsabaia IK, Iurenev AP, Kozdoba OA. Lesions of target organs in arterial hypertension. Kardiologiia 1986; 26(10): 75-80.
23. Krotovskii GS, Pal'tsev MA, Shcherbiuk AN, Turpitko SA. Electron-microscopic study of kidney biopsy specimens in vasorenal hypertension. Sov Med 1980; (6): 33-37.
24. Serov VV, Lebedev SP. Clinical morphology of alcoholism. Arkh Patol 1985; 47(8): 3-14.
25. Nikolaev AIu, Serov VV, Tareeva IE, Varshavskii VA, Lebedev SP. Clinicomorphological characteristics and prognosis of glomerulonephritis in chronic alcoholism. Ter Arkh 1986; 58(8): 115-120.
26. Lebedev SP, Kovtun TI, Sukhova GK. Morphology and various problems of the pathogenesis of alcoholic microangiopathy. Arkh Patol 1986; 48(10): 26-33.
27. Lebedev SP, Vinogradova LG, Sukhova GK. Alcoholic hyalin and interstitial filaments as markers of alcoholic damage of internal organs. Arkh Patol 1984; 46(11): 52-58.
28. Serov VV, Lebedev SP. Clinical morphology of visceral alcoholism. Vestn Akad Med Nauk SSSR 1988; (3): 48-53.
29. Serov VV, Lebedev SP, Vinogradova LG, Mukhin AS, Sukhova GK. Intermediate filaments in the lung macrophages and endothelial cells in chronic alcoholism and suppurativedestructive lung diseases. Biull Eksp Biol Med 1982; 94(12): 92-94.
30. Tarasova NS, Beloborodova EI. Immunological aspects of circulating immune complexes in kidney diseases in patients with chronic alcoholism. Ter Arkh 1998; 70(12): 61-63.
31. Tarasova NS, Beloborodova EI. Hormonal and immunological aspects of renal lesions in patients with chronic alcoholism. Ter Arkh 2003; 75(11): 73-6.
32. Mukhin NA, Dedov II, Shestakova MV, Pal'tsev MA, Varshavskii VA, Severgina ES, Ponomarev AB, Nikolaev AIu, Okunev DIu. The functional kidney reserves of diabetics. Ter Arkh 1990; 62(2): 107-110.
33. Severgina LO, Leonova LV, Severgina ES, Gurevich AI, Menovshchikova LB, Petrukhina IuV, Rapoport LM. Coupling between the hemodynamic parameters and the morphological changes in the kidney in children with congenital hydronephrosis. Arkh Patol 2011; 73(2): 14-17.
34. Leonova LV, Severgina ES, Popova OP, Konovalov DM, Petruchina IuV, Simonova NA. Transforming growth factor as a marker beta of nephrogenetic disturbance in congenital obstructive uropathies. Arkh Patol 2007; 69(4): 35-38.
35. Cheskis AL, Leonova LV, Severgina ES, Ostapko MS, Simonova NA, Al'-Kadi KM. Renal development long after correction of primary non-refluxing forms of megaureter in children. Urologiia 2006; (5): 74-80.
36. Jargin SV. Renal biopsy research with implications for therapy of glomerulonephritis. Curr Drug ther 2012; 7(4): 263-267. [DOI via Crossref]   
37. Seymour AE, Spargo BH, Penksa R. Contributions of renal biopsy studies to the understanding of disease. Am J Pathol 1971; 65(3): 550-598.
38. Kuroda T, Tanabe N, Kobayashi D, Wada Y, Murakami S, Nakano M, Narita I. Significant association between renal function and amyloid-positive area in renal biopsy specimens in AL amyloidosis. BMC Nephrol 2012; 13(1): 118. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
39. Jensen K, Gluud C. The Mallory body: morphological, clinical and experimental studies (Part 1 of a literature survey). Hepatology 1994; 20(4 Pt 1): 1061-1077.
40. French SW, Katsuma Y, Ray MB, Swierenga SH. Cytoskeletal pathology induced by ethanol. Ann N Y Acad Sci 1987; 492: 262-276. [DOI via Crossref]    [Pubmed]   
41. Cecchin E, De Marchi S. Alcohol misuse and renal damage. Addict Biol 1996; 1: 7-17. [DOI via Crossref]    [Pubmed]   
42. Shilov EM, Tareeva IE, Ivanov AA, Troepol'skaia OV, Krasnova TN, Varshavskii VA, Proskurneva EP, Ivanova LV, Khudova IIu, Miroshnichenko NG. The course and prognosis of mesangioproliferative glomerulonephritis. Ter Arkh 2002; 74(6): 11-18.
43. Borisov VV, Vashurina TV, Voznesenskaya TS, Zrobok OI, Kartamysheva NN, Kozlovskaia LV. Clinical recommendations according to syndromes. In: Mukhin NA (ed) Nephrology. National manual, Geotar-media, Moscow, Russia, pp 93-161, 2009. (Russian)
44. Ratner MIa, Fedorova ND, Makurov AI. The tubulointerstitial changes in different clinical and morphological types of chronic glomerulonephritis. Urol Nefrol (Mosk) 1997; (2): 16-19.
45. Varshavskii VA, Laurinavichius AA, Zhigalin VG. Characteristics of primary glomerulonephritis (on the basis of kidney biopsies of the Pathology Department, I.M. Sechenov Moscow Medical Academy, from 1980 to 1989). Arkh Patol 1992; 54(6): 36-40.
46. Ratner M, Serov VV, Warschavski WA, Rosenfeld B, Subkin ML, Novikov ID, Sinn W, Klinkmann H. Recommendations for a clinical classification of chronic glomerulonephritis. Z Urol Nephrol 1987; 80(5): 271-279.
47. Shilov EM, Tareeva IE, Ivanov AA, Troepol'skaia OV, Krasnova TN, Varshavskii VA, Proskurneva EP, Ivanova LV, Khudova IIu, Miroshnichenko NG. The course and prognosis of mesangioproliferative glomerulonephritis. Ter Arkh 2002; 74(6): 11-18.
48. Serov VV. The purpose of clinical morphology is diagnosis. Klin Med (Mosk) 1990; 68(4): 143-4.
49. Ratner MIa, Serov VV, Rozenfel'd BI, Varshavskii VA, Brodskii MA. Linicomorphological variants and prognosis of chronic glomerulonephritis. Ter Arkh 1983; 55(6): 10-4.
50. Serov VV, Varshavsky VA, Schill H, Nizze H. Incidence of glomerular diseases in kidney biopsy materials using WHO classification. Zentralbl Allg Pathol 1986; 132(5-6): 471-475.
51. Ratner MIa, Serov VV, Varshavskii VA, Brodskii MA, Makurov AI. Functional and morphological characteristics of a hematuric form of chronic glomerulonephritis. Klin Med (Mosk) 1990; 68(6): 54-57.
52. Severgina ES. Ultrastructural heterogeneity of "minimal changes" in the kidney glomeruli, detected by light optics. Arkh Patol 1991; 53(2): 53-58.
53. Serov VV, Varshavskii VA, Gasanov AB. Mesangioproliferative glomerulonephritis with IgM deposits as an independent form of nephritis. Arkh Patol 1990; 52(2): 19-23.
54. Varshavskii VA, Proskurneva EP, Gasanov AB, Severgina LO, Shestakova LA. Subdivision of certain morphological variants of chronic glomerulonephritis. Arkh Patol 1999; 61(5): 40-46.
55. Gasanov AB, Varshavskii VA, Serov VV. The morphological heterogeneity of mesangioproliferative glomerulonephritis. Arkh Patol 1990; 52(9): 46-51.
56. Pal'tsev MA, Iargin SV, Krotovskii GS, Turpitko SA, Mamedov DM. Importance of morphologic examination of the kidneys of patients with vasorenal hypertension for predicting the results of surgical treatment. Arkh Patol 1986; 48(6): 34-40.
57. Iargin SV. Nosological characteristics of the morphogenesis of nephrosclerosis. Arkh Patol 1986; 48(7): 55-63.
58. Iargin SV. Morphological characteristics of nephrosclerosis of different etiologies. Arkh Patol 1985; 47(10): 62-70.
59. Iargin SV. The message about unreliability of publications. Klin Khir 2011; (6): 69-70.
60. Severgina LO. Comparative characteristics of morphologic types of mesangiocapillary glomerulonephritis (morphologic correlation analysis). Arkh Patol 1994; 56(3): 63-65.
61. Maruyama K, Tomizawa S, Seki Y, Arai H, Kuroume T. Inhibition of vascular permeability factor production by ciclosporin in minimal change nephrotic syndrome. Nephron 1992; 62(1): 27-30. [DOI via Crossref]    [Pubmed]   
62. Winyard PJ, Bao Q, Hughes RC, Woolf AS. Epithelial galectin-3 during human nephrogenesis and childhood cystic diseases. J Am Soc Nephrol 1997; 8(11): 1647-57.
63. Ratner MIa, Serov VV, Varshavskii VA, Novikov ID, Rozenfel'd BI. New classification of chronic glomerulonephritis. Klin Med (Mosk) 1987; 65(4): 6-11.
64. Churg J, Sobin LH. Renal disease. Classification and atlas of glomerular diseases, Igaku-Shoin, Tokyo, Japan, 1982.
65. Nizze H, Mann E, Stropahl G, Schmidt W. Glomerul�re Krankheiten in der Nierenbiopsie. Korrelation klinischer Syndrome mit histologischen Typen. Pathologe 2003; 24(6): 421-432. [DOI via Crossref]    [Pubmed]   
66. Rutkowski B. Highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe. Nephrol Dial Transplant 2006; 21(1): 4-10. [DOI via Crossref]    [Pubmed]   
67. Falk RJ, Jennette JCh, Nachman PH. In: Brenner BM (ed) Brenner & Rector's The Kidney, 6th edition, Saunders Co., Philadelphia, USA, pp. 1263-1349, 2000.
68. Ratner MIa, Tomilina NA, Klinkman Kh, Shmitt E, Kreger E. Prolonged treatment of mesangioproliferative glomerulonephritis with a cytostatic agent and prednisolone and a combination of a cytostatic agent, prednisolone an anticoagulant and an antiaggregant. Ter Arkh 1980; 52(8): 106-110.
69. Ratner MIa, Biriukova LS, Makurov AI. Indications and effectiveness of combined therapy in chronic glomerulonephritis. Ter Arkh 1987; 59(8): 29-34.
70. Ratner MIa, Serov VV, Stenina IN, Fedorova ND, Shumakov VI. The importance of the clinical classification of chronic glomerulonephritis for the prognosis of its progression and of the efficacy of therapy. Ter Arkh 1996; 68(6): 10-13.
71. Tareeva IE, Gordovskaia NB, Gladskikh OP, Ivanov AA, Krasnova TN. Treatment of chronic glomerulonephritis with cytostatics. Ter Arkh 1989; 61(6): 9-14.
72. Ratner MIa, Tomilina NA, Serov VV. Long-term use of a combination of immunosuppressants, and antiaggregant and an anticoagulant in the treatment of glomerulonephritis. Ter Arkh 1979; 51(6): 43-47.
73. Serov VV, Pal'tsev MA, Mukhin NA, Tareeva IE, Kozlovskaia (Lysenko) LV, Varshavskii VA, Ratner MIa. The key problems of glomerulonephritis. Ter Arkh 1992; 64(6): 5-10.
74. Kamyshova ES, Shvetsov MIu, Shestakov AE, Kutyrina IM, Nosikov VV. Association of gene TP53 polymorphic marker Pro72Arg with clinical characteristics of chronic glomerulonephritis. Ter Arkh 2011; 83(6): 27-32.
75. Severgina ES, Pal'tsev MA. Hypoplastic dysplasia as one of the forms of nephropathy. Arkh Patol 1989; 51(10): 58-63.
76. Squiers EC, Morden RS, Bernstein J. Renal multicystic dysplasia: an occasional manifestation of the hereditary renal adysplasia syndrome. In: Opitz JM, Bernstein J, Spano LM (eds) Topics in pediatric genetic pathology, Alan R. Liss Inc., New York, USA, pp 279-284, 1987.
77. Kakkar N, Menon S, Radotra BD. Histomorphology of renal dysplasia - an autopsy study. Fetal Pediatr Pathol 2006; 25(2): 73-86. [DOI via Crossref]    [Pubmed]   
78. Woolf AS, Price KL, Scambler PJ, Winyard PJ. Evolving concepts in human renal dysplasia. J Am Soc Nephrol 2004; 15(4): 998-1007. [DOI via Crossref]    [Pubmed]   
79. Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 2013; 24(3): 364-375. [DOI via Crossref]    [Pubmed]   
80. Cheskis AL, Severgina ES, Leonova LV, Ostapko MS. Status and development of the kidney after surgical treatment of hydronephrosis in children. Urologiia. 2002; (4): 39-43.
81. Severgina ES. Morphology and pathogenesis of insulin-dependent diabetes mellitus. Habilitation thesis, I.M. Sechenov Medical Academy, Moscow, Russia, 1995. (Russian)
82. Galperin EI, Diuzheva TG, Petrovsky PF, Chevokin AYu, Dokuchayev KV, Rabinovich SE, Gitel EP, Kuzovlev NF, Platonova LV. Results of pancreatic blood shunting into the systemic blood flow in insulin-dependent diabetics. HPB Surg 1996; 9(4): 191-197. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
83. Siplivyi VA, Beresnev AV. The late results of deportalization of the pancreatic blood flow in patients with type-1 diabetes mellitus. Klin Khir 1998; (11): 9-12.
84. Nikonenko AS, Kovalev AA, Zavgorodnii SN, Volkova NA. Surgical treatment of insulin-dependent diabetes mellitus and its complications. Khirurgiia (Mosk) 1996; (2): 81-83.
85. Shraer TI, Rozina NS. Late results of pancreatic blood outflow deportalization and its significance in the combined modality treatment of diabetes mellitus. Probl Endokrinol (Mosk) 1992; 38(5): 49-52.
86. Torgunakov SA, Torgunakov AP. Possible causes of thrombus-related hazard of a distal splenorenal venous anastomosis. Angiol Sosud Khir 2010; 16(4): 184-188.
87. Ivanov PA, Golikov PP, Shcherbiuk AN, Gvakhariia GN, Syromiatnikova ED, Guliaev VA, Nikolaeva NIu. Characteristics of the postoperative period in diabetes mellitus type 1 in patients with distal splenorenal anastomosis. Sov Med 1990; (2): 17-19.
88. Gal'perin EI, Shraer TI, Diuzheva TG, Kuzovlev NF, Bol'shakova TD. Experimental basis and initial clinical experience with the surgical treatment of diabetes mellitus. Khirurgiia (Mosk) 1987; (2): 64-70.
89. Gal'perin EI, Diuzheva TG, Kuzovlev NF, Bol'shakova TD, Gitel' EP. Surgical correction of metabolism in diabetes mellitus. Khirurgiia (Mosk) 1988; (9): 6-11.
90. Putintsev AM, Shraer TI, Sergeev VN, Maslov MG, Strukova OA. Variants of surgical management for severe arterial hypertension combined with type 2 diabetes mellitus. Angiol Sosud Khir 2010; 16(2): 120-125.
91. Severgina ES, Diuzheva TG. Morphologic and functional changers in B-cells and vessels of the islands of Langerhans in patients with insulin-dependent diabetes mellitus. Arkh Patol 1996; 58(5): 40-47.
92. Severgina ES, Diuzheva TG, Razgulina LE, Stakheev IB. Is localization of B-cells in the acini a normal condition or the sign of compensatory process in insulin-dependent diabetes mellitus? Arkh Patol 1992; 54(12): 18-23.
93. Severgina E, Dyuzheva T, Paltsev M. Acinar B-cells in pancreas in insulin-dependent diabetic patients. The right to exist. Pathol Res Pract 1993; 189(3): 298-299. [DOI via Crossref]   
94. Severgina ES, Ponomarev AB, Diuzheva TG, Shestakova MV, Maiorova EM. Diabetic glomerulonephritis - the first stage of diabetic glomerulopathy. Arkh Patol 1994; 56(4): 44-50.
95. Severgina ES, Ponomarev AB, Diuzheva TG, Shestakova MV, Maiorova EM. Diabetic glomerulosclerosis - a prolonged stage of diabetic glomerulopathy. Arkh Patol 1994; 56(4): 50-55.
96. Spencer J, Peakman M. Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell. Clin Exp Immunol 2009; 155(2): 125-127. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
97. Richardson SJ, Morgan NG, Foulis AK. Pancreatic Pathology in Type 1 Diabetes Mellitus. Endocr Pathol 2014; [DOI via Crossref]    [DOI via Crossref]   
98. Dizdar O1, Kahraman S, Gen�toy G, Ertoy D, Arici M, Altun B, Yasavul U, Turgan C. Membranoproliferative glomerulonephritis associated with type 1 diabetes mellitus and Hashimoto's thyroiditis. Nephrol Dial Transplant 2004; 19(4): 988-989. [DOI via Crossref]    [Pubmed]   
99. Hironaka K, Makino H, Ikeda S, Haramoto T, Ota Z. Nondiabetic renal disease complicating diabetic nephropathy. J Diabet Complications 1991; 5(2-3): 148-149.
100. Severgina ES, Ponomarev AB. Patho- and morphogenesis of diabetes mellitus and early diabetic nephropathy. Arkh Patol 1988; 50(4): 80-85.
101. Gonzalez Suarez ML, Thomas DB, Barisoni L, Fornoni A. Diabetic nephropathy: Is it time yet for routine kidney biopsy? World J Diabetes 2013; 4(6): 245-255.
102. Jargin SV. Chernobyl-related bladder lesions: New interpretation required. J Interdiscipl Histopathol. Online First: 28 Jan, 2014; [DOI via Crossref]    [DOI via Crossref]   
103. Bonomini V, Dalmastri GP, Migliori V, Mioli V, Zucchelli P. A study of the correlations between renal biopsy and other diagnostic investigations in, "primary" and, "superimposed" pyelonephritis. Urol Int 1964; 18: 58-70. [DOI via Crossref]    [Pubmed]   
104. Dhai A. The research ethics evolution: From Nuremberg to Helsinki. S Afr Med J 2014; 104(3): 178-180. [DOI via Crossref]    [Pubmed]   
105. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964; last amended by the 64th WMA General Assembly, Fortaleza, Brazil, October 2013 Available via http://www.wma.net/en/30publications/10policies/b3/index.html (Accessed 11 March 2014)
106. WMA International Code of Medical Ethics. Adopted by the 3rd General Assembly of the World Medical Association, London, England, October 1949; last amended by the 57th WMA General Assembly, Pilanesberg, South Africa, October 2006. Available via http://www.wma.net/en/30publications/10policies/c8/ (Accessed 11 March 2014)

This Article Cited By the following articles

Alcohol Consumption in Russia and Some Aspects of Public Health
Int J High Risk Behav Addict 2016; 5(1): .

1
 
On the endoscopic methods used in pediatrics with questionable indications
Annals of Medicine and Surgery 2016; 10(): 8.

2
 
Invasive procedures with questionable indications
Annals of Medicine and Surgery 2014; 3(4): 126.

3
 
Societal and political will for cancer prevention in Russia
The Lancet Oncology 2014; 15(8): e298.

4
 

How to Cite this Article
Pubmed Style

Sergei V. Jargin. Renal Biopsy for Research: An Overview of Russian Experience. J Interdiscipl Histopathol. 2014; 2(2): 88-95. doi:10.5455/jihp.20140312020838



Web Style

Sergei V. Jargin. Renal Biopsy for Research: An Overview of Russian Experience. www.scopemed.org/?mno=151430 [Access: August 24, 2017]. doi:10.5455/jihp.20140312020838



AMA (American Medical Association) Style

Sergei V. Jargin. Renal Biopsy for Research: An Overview of Russian Experience. J Interdiscipl Histopathol. 2014; 2(2): 88-95. doi:10.5455/jihp.20140312020838



Vancouver/ICMJE Style

Sergei V. Jargin. Renal Biopsy for Research: An Overview of Russian Experience. J Interdiscipl Histopathol. (2014), [cited August 24, 2017]; 2(2): 88-95. doi:10.5455/jihp.20140312020838



Harvard Style

Sergei V. Jargin (2014) Renal Biopsy for Research: An Overview of Russian Experience. J Interdiscipl Histopathol, 2 (2), 88-95. doi:10.5455/jihp.20140312020838



Turabian Style

Sergei V. Jargin. 2014. Renal Biopsy for Research: An Overview of Russian Experience. Journal of Interdisciplinary Histopathology, 2 (2), 88-95. doi:10.5455/jihp.20140312020838



Chicago Style

Sergei V. Jargin. "Renal Biopsy for Research: An Overview of Russian Experience." Journal of Interdisciplinary Histopathology 2 (2014), 88-95. doi:10.5455/jihp.20140312020838



MLA (The Modern Language Association) Style

Sergei V. Jargin. "Renal Biopsy for Research: An Overview of Russian Experience." Journal of Interdisciplinary Histopathology 2.2 (2014), 88-95. Print. doi:10.5455/jihp.20140312020838



APA (American Psychological Association) Style

Sergei V. Jargin (2014) Renal Biopsy for Research: An Overview of Russian Experience. Journal of Interdisciplinary Histopathology, 2 (2), 88-95. doi:10.5455/jihp.20140312020838